文献速递心脑血管急症消化、代谢与肾脏急症

HEART评分对急诊科胸痛患者6个月预后预测的性能:一项回顾性队列分析

Performances of HEART score to predict 6-month prognostic of emergency department patients with chest pain: a retrospective cohort analysis.
PubMed 文献 · Eur J Emerg Med · 2023-04-05
一句话结论在急诊非创伤性胸痛患者中,低危HEART评分与6个月主要不良心脏事件(MACE)风险极低相关(阴性预测值99%)。

该回顾性队列研究纳入某三级转诊大学医院急诊科2015年1月1日至2017年12月31日就诊的非创伤性胸痛患者,从7040例中随机抽取20%样本,排除ST段抬高>1 mm、休克及无电话号码者,最终1099例纳入分析。主要终点为6个月MACE(心血管死亡、心肌梗死或非计划血运重建),发生率为18.3%(n=205)。HEART评分在1047例中回顾性计算,低危、中危、高危组MACE发生率分别为0.98%、38.02%、62.21%,低危组排除6个月MACE的阴性预测值为99%。常规诊疗的敏感性97.38%、特异性98.24%、阳性预测值95.5%、阴性预测值99%,总体准确率98.00%。

要点

  • 低危HEART评分排除6个月MACE的阴性预测值为99%,对应MACE发生率仅0.98%。
  • 中危HEART评分患者6个月MACE发生率为38.02%,高危为62.21%。
  • 常规诊疗排除MACE的敏感性97.38%、特异性98.24%、阴性预测值99%,总体准确率98.00%。
  • 总体6个月MACE发生率为18.3%(n=205),788例(71.70%)出院、311例(28.30%)住院。

适用人群与场景

  • 某三级转诊大学医院急诊科就诊的非创伤性胸痛患者,年龄等纳入标准原文未详述。
  • 排除标准:ST段抬高>1 mm、休克、无电话号码。
  • 最终分析1099例,其中788例(71.70%)出院、311例(28.30%)住院。

诊断标准与关键阈值

  • HEART评分按急诊最终报告回顾性计算,低危、中危、高危分组界值原文未给出。
  • 主要终点MACE定义为6个月内发生心血管死亡、心肌梗死或非计划血运重建。

研究设计与关键结果

  • 研究类型:回顾性队列分析;从2015年1月1日至2017年12月31日7040例胸痛患者中随机抽取20%样本,筛查1119例,排除失访后1099例纳入分析。
  • 干预与对照:无随机干预,评估HEART评分及急诊常规诊疗对6个月MACE的预测性能。
  • 主要终点:6个月MACE发生率为18.3%(n=205);HEART评分在1047例中计算,低危组MACE发生率0.98%、中危组38.02%、高危组62.21%。
  • 低危HEART评分排除6个月MACE的阴性预测值为99%。
  • 常规诊疗诊断性能:敏感性97.38%、特异性98.24%、阳性预测值95.5%、阴性预测值99%,总体准确率98.00%。

证据类型、等级与局限

  • 证据类型:回顾性队列分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 在急诊非创伤性胸痛患者中,低危HEART评分与6个月MACE风险极低相关(阴性预测值99%),作者结论认为低HEART评分与6个月MACE风险极低相关。
  • 常规诊疗对6个月MACE的敏感性97.38%、特异性98.24%,HEART评分与常规诊疗对住院或出院适当性的影响比较,原文未给出结论。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND AND IMPORTANCE: Chest pain is a frequent cause of patient admissions in emergency departments (EDs). Clinical scores can help in the management of chest pain patients with an undefined impact on the appropriateness of hospitalization or discharge when compared to usual care.

OBJECTIVES: The aim of this study was to assess the performances of the HEART score to predict the 6-month prognostic of patients presenting to the ED of a tertiary referral university hospital with non-traumatic chest pain.

DESIGN, SETTINGS, AND PARTICIPANTS: From 7040 patients presenting with chest pain from 1 January 2015 to 31 December 2017, after applying exclusion criteria (ST-segment elevation >1 mm, shock, absence of telephone number) we selected a sample of 20% chosen randomly. We retrospectively assessed the clinical course, definitive diagnosis, and HEART score according to ED final report. Follow-up was made by telephone interview with discharged patients. In hospitalized patients, clinical records were analyzed to evaluate major adverse cardiac events (MACE) incidence.

OUTCOME MEASURE AND ANALYSIS: The primary endpoint was MACE, comprising cardiovascular death, myocardial infarction, or unscheduled revascularization at 6 months. We assessed the diagnostic performance of the HEART score in ruling out MACE at 6 months. We also assessed the performance of ED usual care in the management of chest pain patients.

RESULTS: Of 1119 screened, 1099 were included for analysis after excluding patients lost to follow-up; 788 patients (71.70%) had been discharged and 311 (28.30%) were hospitalized. Incident MACE was 18.3% ( n = 205). The HEART score was retrospectively calculated in 1047 patients showing increasing MACE incidence according to risk category (0.98% for low risk, 38.02% for intermediate risk, and 62.21% for high risk). Low-risk category allowed to safely exclude MACE at 6 months with a negative predictive value (NPV) of 99%. Usual care diagnostic performance showed 97.38% sensitivity, 98.24% specificity, 95.5% positive predictive value, and 99% NPV, with an overall accuracy of 98.00%.

CONCLUSIONS: In ED patients with chest pain, a low HEART score is associated with a very low risk of MACE at 6 months.

来源:Eur J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Fiore G, Pinto G, Preda A, et al. Performances of HEART score to predict 6-month prognostic of emergency department patients with chest pain: a retrospective cohort analysis. Eur J Emerg Med. 2023. PMID: 37040660. doi:10.1097/MEJ.0000000000001022

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。